eMedicine Specialties > Emergency Medicine > Infectious Diseases

Ascaris Lumbricoides: Treatment & Medication

Author: Aaron Dora-Laskey, MD, Emergency Physician, Physician Management Group, Dayton, Ohio
Coauthor(s): Ugo Anthony Ezenkwele, MD, MPH, Assistant Professor of Emergency Medicine, Department of Emergency Medicine, New York University School of Medicine/Bellevue Hospital Center; Eric L Weiss, MD, DTM&H, Director of Stanford Travel Medicine, Medical Director of Stanford Lifeflight, Assistant Professor, Departments of Emergency Medicine and Infectious Diseases, Stanford University School of Medicine
Contributor Information and Disclosures

Updated: Jul 30, 2009

Treatment

Emergency Department Care

  • Early infection (larval migration)
    • Inhaled beta-agonists may be indicated.
    • Steroids for pulmonary symptoms are controversial.
    • Whether anthelmintic therapy is effective against larval stages is unclear. (Stool ova microscopy will likely be negative at this phase). Because infection in the early phase is rarely serious, generally treatment is delayed until definitive diagnosis can be made.
  • Established infection (adult phase)
    • Benzimidazoles are the mainstay of treatment of symptomatic and asymptomatic infections. They are poorly systemically absorbed and thus have low human toxicity and exert their action directly on worms. The most common members of this family are albendazole and mebendazole.  
    • Treatment of bowel obstruction includes intravenous hydration, nasogastric suctioning, electrolyte monitoring, and laparotomy if conservative measures fail. Colonoscopy and esophagogastroduodenoscopy (EGD) may be useful in removing obstructing masses of worms.
    • Piperazine citrate, a helminth paralytic, has been suggested in cases of obstruction; however, it is no longer commercially available in the United States.
    • Hepatobiliary ascariasis typically responds to similarly conservative therapy, but it may require invasive intervention (eg, ERCP).

Consultations

Bowel or hepatobiliary obstruction may require surgical or gastroenterologic consultation.

Medication

Benzimidazoles are effective for the treatment of intestinal ascariasis, although some authors recommend against their use in the first year of life and during pregnancy due to their teratogenic effects in animal studies. The most commonly recommended agents are albendazole and mebendazole. Ivermectin and pyrantel pamoate are alternatives, the latter having been suggested for pregnant patients in whom benzimidazoles are contraindicated. An anthelmintic agent from China, tribendimidine (at a dose of 300 mg), has been shown to be as efficacious as albendazole.9,10

Anthelmintics

Parasite biochemical pathways are sufficiently different from the human host to allow selective interference by chemotherapeutic agents in relatively small doses.


Albendazole (Albenza)

Decreases ATP production in worm, causing energy depletion, immobilization, and finally death.

Adult

400 mg/d PO single dose; repeat in 3 wk if not cured

Pediatric

<2 years: 200 mg/d PO single dose; repeat in 3 wk if not cured
>2 years: Administer as in adults

Coadministration with carbamazepine may decrease efficacy; dexamethasone and praziquantel may increase toxicity

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Discontinue use if LFT values increase significantly (resume when levels decrease to pretest values); GI symptoms (nausea, vomiting, diarrhea) or CNS symptoms (dizziness, headache, meningeal signs) may occur; granulocytopenia, thrombocytopenia, and pancytopenia have been reported


Mebendazole (Vermox)

Causes worm death by selectively and irreversibly blocking uptake of glucose and other nutrients in susceptible adult intestine where helminths dwell.

Adult

100 mg PO bid on 3 consecutive days
Administer second course if not cured within 3-4 wk

Pediatric

<2 years: Not established
>2 years: Administer as in adults

Carbamazepine and phenytoin may decrease effects

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Adjust dose in hepatic impairment; GI symptoms (nausea, vomiting, abdominal pain, diarrhea) and CNS symptoms (headache, dizziness) are common; alopecia may be associated with high doses; rare reactions include angioedema, seizures, and agranulocytosis


Piperazine citrate

Recommend for GI or biliary obstruction secondary to ascariasis; causes flaccid paralysis of the helminth by blocking response to worm muscle to acetylcholine.

Adult

3.5 g PO qd for 2 d

Pediatric

75 mg/kg PO qd for 2 d; not to exceed 3.5 g/dose

Coadministration with chlorpromazine may increase toxicity

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Most commonly reported reactions include GI and CNS effects; discontinue therapy if effects become significant; prolonged, repeated, or excessive therapy should be avoided because of potential neurotoxicity


Pyrantel pamoate (Antiminth)

Depolarizing neuromuscular blocking agent; inhibits cholinesterases, resulting in spastic paralysis of worm.

Adult

11 mg/kg/dose PO as single dose; not to exceed 1 g

Pediatric

Administer as in adults

Pyrantel and piperazine are mutually antagonistic and should not be used concomitantly

Documented hypersensitivity; hepatic disease

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Caution in liver impairment, anemia, and malnutrition; GI effects, headache, insomnia, rash, tenesmus, and elevated LFT values may occur


Ivermectin (Stromectol)

Binds selectively with glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, causing cell death.

Adult

150-200 mcg/kg PO once

Pediatric

Administer as in adults

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Serious reactions include Stevens-Johnson syndrome, asthma exacerbation, and vision loss (rare); common reactions include pruritus, rash, headache, myalgias, and elevated LFT values


Levamisole (Ergamisol)

May inhibit worm copulation via agonism of L-subtype nicotinic acetylcholine receptors in male nematode muscles.

Adult

2.5 mg/kg PO once

Pediatric

Administer as in adults

Increases toxicity and serum levels of phenytoin; causes disulfiram reactions when taken with alcohol

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Agranulocytosis can occur asymptomatically

More on Ascaris Lumbricoides

Overview: Ascaris Lumbricoides
Differential Diagnoses & Workup: Ascaris Lumbricoides
Treatment & Medication: Ascaris Lumbricoides
Follow-up: Ascaris Lumbricoides
Multimedia: Ascaris Lumbricoides
References

References

  1. Albonico M, Ramsan M, Wright V, et al. Soil-transmitted nematode infections and mebendazole treatment in Mafia Island schoolchildren. Ann Trop Med Parasitol. Oct 2002;96(7):717-26. [Medline].

  2. Luoba AI, Wenzel Geissler P, Estambale B, et al. Earth-eating and reinfection with intestinal helminths among pregnant and lactating women in western Kenya. Trop Med Int Health. Mar 2005;10(3):220-7. [Medline].

  3. Williams-Blangero S, Subedi J, Upadhayay RP, et al. Genetic analysis of susceptibility to infection with Ascaris lumbricoides. Am J Trop Med Hyg. Jun 1999;60(6):921-6. [Medline].

  4. Mwanza JC. Lacrimal drainage obstruction by Ascaris lumbricoides. Bull Soc Belge Ophtalmol. 2004;71-3. [Medline].

  5. Karatepe O, Tukenmez M, Salmashogul A, et al. Ascaris as a leading point for small-bowel intussusception in an adult: a rare cause of intussusception. Am J Emerg Med. Mar 1 2008;26(3):381.e3-381.e4.

  6. Jung O, Ditting T, Grone HJ, Geiger H, Hauser IA. Acute interstitial nephritis in a case of Ascaris lumbricoides infection. Nephrol Dial Transplant. Jun 2004;19(6):1625-8. [Medline].

  7. Selimoglu MA, Ozturk CF, Ertekin V. A rare manifestation of ascariasis: encephalopathy. J Emerg Med. Jan 2005;28(1):87-8. [Medline].

  8. Arya PK, Kukreti R, Arya M, Gupta SN. Magnetic resonace appearance of gall bladder ascariasis. Indian J Med Sci. May 2005;59(5):208-10. [Medline].

  9. Xiao SH, Hui-Ming W, Tanner M, Utzinger J, Chong W. Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop. Apr 2005;94(1):1-14. [Medline].

  10. Steinmann P, Zhou XN, Du ZW, Jiang JY, Xiao SH, Wu ZX, et al. Tribendimidine and Albendazole for Treating Soil-Transmitted Helminths, Strongyloides stercoralis and Taenia spp.: Open-Label Randomized Trial. PLoS Negl Trop Dis. 2008;2(10):e322. [Medline].

  11. Bell DR. Soil transmitted helminths. In: Lecture Notes on Tropical Medicine. Boston: Blackwell Science; 1985:167-192.

  12. Cappello M, Hotez PJ. Intestinal Nematodes. Philadelphia: Churchill-Livingstone; 2003:1331-1333.

  13. Freedman DO. Intestinal nematodes. In: Gorbach, ed. Infectious Diseases. Philadelphia: WB Saunders; 1992:2003-2008.

  14. Gilles HM. Intestinal nematode infections. In: GT Strickland, ed. Hunter's Tropical Medicine. Philadelphia: WB Saunders; 1984:620-644.

  15. Liu LX, Weller PF. Antiparasitic drugs. N Engl J Med. May 2 1996;334(18):1178-84. [Medline].

  16. Muennig P, Pallin D, Sell RL, Chan MS. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med. Mar 11 1999;340(10):773-9. [Medline].

  17. Talaat KR, Nutman TB. Parasitic Diseases. In: Mason, ed. Murray & Nadel's Textbook of Respiratory Medicine. Philadelphia: Saunders; 2003:1090-1092.

  18. Urbani C, Albonico M. Anthelminthic drug safety and drug administration in the control of soil-transmitted helminthiasis in community campaigns. Acta Trop. May 2003;86(2-3):215-21. [Medline].

Further Reading

Keywords

Ascaris lumbricoides, A lumbricoides, ascariasis, roundworm, intestinal parasite, roundworm treatment, roundworm symptoms, intestinal roundworm, human parasite, nematode infection, malnutrition, iron-deficiency anemia, bowel obstruction, Ascaris suum, eosinophilic pneumonia, Löffler syndrome

Contributor Information and Disclosures

Author

Aaron Dora-Laskey, MD, Emergency Physician, Physician Management Group, Dayton, Ohio
Aaron Dora-Laskey, MD is a member of the following medical societies: American Academy of Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Ugo Anthony Ezenkwele, MD, MPH, Assistant Professor of Emergency Medicine, Department of Emergency Medicine, New York University School of Medicine/Bellevue Hospital Center
Ugo Anthony Ezenkwele, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, National Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Eric L Weiss, MD, DTM&H, Director of Stanford Travel Medicine, Medical Director of Stanford Lifeflight, Assistant Professor, Departments of Emergency Medicine and Infectious Diseases, Stanford University School of Medicine
Eric L Weiss, MD, DTM&H is a member of the following medical societies: American College of Emergency Physicians, American College of Occupational and Environmental Medicine, American Medical Association, American Society of Tropical Medicine and Hygiene, Physicians for Social Responsibility, Southeastern Surgical Congress, Southern Association for Oncology, Southern Clinical Neurological Society, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Mark Louden, MD, FACEP, Assistant Medical Director, Emergency Department, Duke Raleigh Hospital
Mark Louden, MD, FACEP is a member of the following medical societies: American Academy of Emergency Medicine and American College of Emergency Physicians
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Jon Mark Hirshon, MD, MPH, Associate Professor, Department of Emergency Medicine, University of Maryland School of Medicine
Jon Mark Hirshon, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Public Health Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: WebMD Salary Employment

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.